Grants and Publications
Grants received by members of our program and notable publications.
Grants
|
Grant |
Study |
Year received |
|---|---|---|
|
Hereditary/Transthyretin Amyloidosis Canada Research Grant |
Clinical, Sonographic and Electrophysiologic Characteristics of Carpal Tunnel Syndrome in Hereditary and Wild-type Transthyretin Amyloidosis. |
2021 |
|
University of Calgary Cumming School of Medicine Clinical Research Fund Seed Grant Competition |
The prevalence, severity and prognostic utility of frailty assessment in transthyretin amyloidosis cardiomyopathy (the FRAILTY-ATTR Study). |
2021 |
|
Pfizer Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada Grant |
Canadian Cardiac Amyloidosis PyrophosphatE Imaging Registry (CAPER). |
2021 |
|
Quality Improvement Grant to Support the Development of Cardiac Amyloid Centers-Pfizer Global Medical Grant |
A Province-Wide Transthyretin Amyloidosis Cardiomyopathy Care Pathway to Enhance Quality Care Assessment and Delivery in Alberta. |
2021 |
|
Canadian Cardiovascular Society/Pfizer Canada Research Fellowship Grant |
Identifying and Predicting Response to Tafamidis Therapy in Transthyretin Cardiac Amyloidosis Using Cardiac Magnetic Resonance Imaging. |
2021 |
|
Canadian Institutes of Health Research Master’s Award Canada Graduate Scholarship |
Determinants and Monitoring of Response to disease-modifying therapy for Transthyretin Amyloidosis Cardiomyopathy: The ATTR-CM Study. |
2021 |
|
Junior Investigator Global ATTR Amyloidosis Research Award |
ASPIRE - Defining the Role of Extra-cellular Matrix in Transthyretin Fibrillogenesis and Tissue Tropism. |
2021 |
Publications
|
Publication |
Year published |
|---|---|
|
Slomka PJ, Miller RJH. Can Deep Learning Detect Incidental Abnormal Cardiac Uptake related to Amyloidosis on Routine Bone Scintigraphy? JACC Cardiovasc Imaging 2023. In press. |
2023 |
|
Ellen Lewis, Holly Lee, Nowell M. Fine, Robert Miller, Christopher Hahn, Jason Tay, Sameer Chhibber, Etienne Mahe, Victor H.Jimenez-Zepeda. Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM Criteria. Accepted for publication in Clinical Lymphoma, Myeloma and Leukemia December 2022. |
2022 |
|
Kate Elzinga, Shahin Khayambashi, Christopher Hahn, Etienne Mahe, Nowell M. Fine. Amyloidosis and Carpal Tunnel Syndrome: Surgical Technique for Extended Carpal Tunnel Release with Tenosynovium and Transverse Carpal Ligament Biopsies. Accepted for publication in Plastic and Reconstructive Surgery -Global Open November 2022. |
2022
|
|
Roshankar G, White G, Cadet S, Fine N, Chan D, White JA, Jimenez-Zepeda V, Slomka PJ and Miller RJH. Quantitative Cardiovascular Magnetic Resonance and Technetium Pyrophosphate Imaging in Patients with Suspected Cardiac Amyloidosis. J Nucl Cardiol 2022 Oct;29(5):2679-2690. |
2022 |
|
Ellen Lewis, Nowell M. Fine, Robert J. H. Miller, Christopher Hahn, Sameer Chhibber, Etienne Mahe, Jason Tay, Peter Duggan, Sylvia McCulloch, Nizar Bahlis, Paola Neri, Victor H. Jimenez‑Zepeda. Amyloidosis and COVID‑19: Experience From an Amyloid Program in Canada. Accepted for publication in the Annals of Hematology August 2022.
|
2022 |
|
Shahin Khayambashi, Kate Elzinga, Christopher Hahn, Sameer Chhibber, Etienne Mahe, Robert J.H. Miller, James A. White, Jonathan G. Howlett, Victor Jimenez-Zepeda, Nowell M. Fine. Amyloidosis Tissue Confirmation for Tafamidis Eligibility Using Transverse Carpal Ligament and Tenosynovium Biopsy. Accepted for publication in Can J Cardiol June 2022. |
2022 |
|
Nowell M. Fine, Robert Miller. Heart Transplantation for Cardiac Amyloidosis: The Need for High Quality Data to Improve Patient Selection. Accepted for publication in Can J Cardiol May 2022. |
2022 |
|
Angela Lee, Nowell M. Fine, Vera Bril, Diego Delgado, Christopher Hahn. Hereditary Transthyretin Amyloidosis: Case Report of an Unusual Cause presenting with Diarrhea, Anemia, and Peripheral Neuropathy. Accepted for publication in the Journal of Medical Case Reports, May 2022. |
2022 |
|
Biobelemoye Irabor, Jacqueline M Mcmillan, Nowell M. Fine. Assessment and Management of Older Patients with Transthyretin Amyloidosis Cardiomyopathy: Geriatric Cardiology, Frailty Assessment and Beyond. Accepted for publication in Frontiers in Cardiovascular Medicine March 2022. |
2022 |
|
Sperry B, Liu C, Akin E, Bateman T, Bravo P, Chen W, Dilsizian V, Hyafil F, Khor Y, Miller E, Miller RJH, Slart R, Slomka P, and Verberne H. Hot Spot Imaging in Cardiovascular Disease: Joint Position Paper of the SNMMI, ASNC, and EANM. J Nucl Med 2022, in press. |
2022 |
|
Robert JH Miller, Nowell M. Fine. Quantifying is Believing: Techniques for Evaluating Transthyretin Cardiac Amyloidosis Burden For Expanded Clinical Applications. Accepted for publication in the Journal of Nuclear Cardiology, November 2021. |
2022 |
|
Golnaz Roshankar, Geneva C White, Sebastien Cadet, Nowell M. Fine, Denise Chan, James A White, Victor Jimenez-Zepeda, Piotr J Slomka, Robert JH Miller. Quantitative Technetium Pyrophosphate and Cardiovascular Magnetic Resonance in Patients with Suspected Cardiac Amyloidosis. Accepted for publication in the Journal of Nuclear Cardiology August 2021. |
2021 |
|
Nowell M. Fine, Jacqueline M. McMillan. Prevalence and Prognostic Significance of Frailty Among Patients with Transthyretin Amyloidosis Cardiomyopathy. Accepted for publication in Circulation Heart Failure March 2021. |
2021 |
|
Victor H. Jimenez-Zepeda, Holly Lee, Nowell M. Fine, Sylvia McCulloch, Jason Tay, Peter Duggan, Paola Meri, Nizar Bahlis. Cyclophosphamide, Bortezomib and Methylprednisolone (CyBorMe) for the Treatment of AL Amyloidosis: Initial Experience from a Single Center. Accepted by the Indian Journal of Hematology and Blood Transfusion January 2021. |
2021 |
|
Miller RJH, Cadet S, Mah D, Pournazari P, Chan D, Fine N, Berman DS, Slomka PJ. Diagnostic and Prognostic Value of Technetium-99m Pyrophosphate Uptake Quantitation for Transthyretin Cardiac Amyloidosis. J Nucl Cardiol 2021, 28:1835–1845. |
2021 |
|
Miller RJH and Fine NM. Quantifying is Believing: Techniques for Evaluating Transthyretin Cardiac Amyloidosis Burden For Expanded Clinical Applications. J Nucl Cardiol. 2021, in press |
2021 |
|
Angela Russell, Christopher Hahn, Sameer Chhibber, Lawrence Korngut, Nowell M. Fine. Utility of Neuropathy Screening for Wild-Type Transthyretin Amyloidosis Patients. Accepted for publication in the Canadian Journal Neurosciences December 2020. |
2020 |
|
Nowell M. Fine. Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop? Accepted for publication in JACC: Case Reports. November 2020. |
2020 |
|
Nowell M. Fine, James A. White, Victor Jimenez Zepeda, Jonathan G. Howlett. Determinants and Prognostic Significance of Serial Right Heart Function Assessment in Patients with Cardiac Amyloidosis. Canadian Journal of Cardiology 2020;36(3):432-440. |
2020 |
|
Nowell M. Fine. Challenges and Strategies in the Diagnosis of Cardiac Amyloidosis. Canadian Journal of Cardiology 2020;36(3):441-3. |
2020 |
|
Erin Karlstedt, Victor Jimenez-Zepeda, Jonathan G. Howlett, James A. White, Nowell M. Fine. Clinical Experience Using Doxycycline and Ursodeoxycholic Acid for the Treatment of Transthyretin Cardiac Amyloidosis. Accepted for publication in the Journal of Cardiac Failure January 2019;25(3):147-53. |
2019 |
|
Na’ama Avitzur, Alessandro Satriano, Mohammad Afzal, Mariam Narous, Yoko Mikami, Reis Hansen, Gary Dobko, Jacqueline Flewitt, Carmen P. Lydell, Andrew G. Howarth, Nowell M. Fine, James A. White. 3D Myocardial Deformation from Cine MRI as a Marker of Amyloid Protein Burden in Cardiac Amyloidosis: Validation versus T1 mapping based measures. International Journal Cardiovascular Imaging. Dec 2018;34(12):1937-1946 |
2018 |
|
James A. White, Nowell M. Fine. Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis. Current Cardiology Reports. August 2016;18(8):77. |
2016 |